These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23406724)

  • 1. Are biomarkers still helpful in hepatocellular carcinoma?
    Lamerz R
    Digestion; 2013; 87(2):118-20. PubMed ID: 23406724
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma].
    Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
    Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
    J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hepatocellular carcinoma.
    Haydon GH; Hayes PC
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
    Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847
    [No Abstract]   [Full Text] [Related]  

  • 10. New frontiers in biomarkers for hepatocellular carcinoma.
    Giannelli G; Antonaci S
    Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Kubota T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():625-8. PubMed ID: 16149595
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

  • 15. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].
    Yamashiki M; Kosaka Y
    Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
    Aoyagi Y; Yanagi M; Asakura H
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for hepato-cellular carcinoma].
    Etienne JP
    Rev Med Suisse Romande; 1992 Jun; 112(6):501-3. PubMed ID: 1378644
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].
    Matsushima A; Enomoto M; Yokoo Y; Arai M; Kobayashi T; Okuno F; Hirano Y; Sujita K; Eto S; Takagi T
    Rinsho Byori; 1989 Jun; 37(6):683-6. PubMed ID: 2477568
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
    Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
    J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
    Teofănescu I; Gologan E; Stefănescu G; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.